You are currently viewing ICD10 – Companies To Gain From Health Care’s ‘Y2K’ Problem
Healthcare Y2K Problem

ICD10 – Companies To Gain From Health Care’s ‘Y2K’ Problem

We have been working on educating various constituencies about health care information management standards and health care reform and today we were mentioned in the Wall Street Journal regarding ICD-10.

Writing for the WSJ, Brian Gormley writes, Some venture-backed information-technology companies that serve hospitals and health insurers are getting a boost from what analysts call the Y2K of health care. The problem is caused by a coming change in the coding system … the Centers for Medicare and Medicaid Services has mandated that they move from ICD-9 to ICD-10 by Oct. 1, 2013.”

The ICD-10 conversion isn’t the medical industry’s only problem.  …they have to update the electronic format they use to send claims back and forth—a shift from 4010A1 to 5010, a change that is mandated by Jan. 1, 2012, said Michael Arrigo, managing partner of No World Borders Inc., a consulting firm backed by Palos Verdes Venture Partners.”

You can read the full post on the Wall Street Journal here:

IT Companies Stand To Gain From Health Care’s Y2K Problem – Venture Capital Dispatch – WSJ.

Michael F. Arrigo

Michael is Managing Partner & CEO of No World Borders, a leading healthcare management and IT consulting firm. He serves as an expert witness in Federal and State Court and was recently ruled as an expert by a 9th Circuit Federal Judge. He serves as a patent expert witness on intellectual property disputes, both as a Technical Expert and a Damages expert. His vision for the firm is to continue acquisition of skills and technology that support the intersection of clinical data and administrative health data where the eligibility for medically necessary care is determined. He leads a team that provides litigation consulting as well as advisory regarding medical coding, medical billing, medical bill review and HIPAA Privacy and Security best practices for healthcare clients, Meaningful Use of Electronic Health Records. He advises legal teams as an expert witness in HIPAA Privacy and Security, medical coding and billing and usual and customary cost of care, the Affordable Care Act and benefits enrollment, white collar crime, False Claims Act, Anti-Kickback, Stark Law, physician compensation, Insurance bad faith, payor-provider disputes, ERISA plan-third-party administrator disputes, third-party liability, and the Medicare Secondary Payer Act (MSPA) MMSEA Section 111 reporting. He uses these skills in disputes regarding the valuation of pharmaceuticals and drug costs and in the review and audit of pain management and opioid prescribers under state Standards and the Controlled Substances Act. He consults to venture capital and private equity firms on mHealth, Cloud Computing in Healthcare, and Software as a Service. He advises ERISA self-insured employers on cost of care and regulations. Arrigo was recently retained by the U.S. Department of Justice (DOJ) regarding a significant false claims act investigation. He has provided opinions on over $1 billion in health care claims and due diligence on over $8 billion in healthcare mergers and acquisitions. Education: UC Irvine - Economics and Computer Science, University of Southern California - Business, studies at Stanford Medical School - Biomedical Informatics, studies at Harvard Medical School - Bioethics. Trained in over 10 medical specialties in medical billing and coding. Trained by U.S. Patent and Trademark Office (USPTO) and PTAB Judges on patent statutes, rules and case law (as a non-attorney to better advise clients on Technical and Damages aspects of patent construction and claims). Mr. Arrigo has been interviewed quoted in the Wall Street Journal, New York Times, and National Public Radio, Fortune, KNX 1070 Radio, Kaiser Health News, NBC Television News, The Capitol Forum and other media outlets. See and for more about the company.

Leave a Reply